Amy van de Ven

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite intensive multimodal treatment of sarcomas, a heterogeneous group of malignant tumors arising from connective tissue, survival remains poor. Candidate-based targeted treatments have demonstrated limited clinical success, urging an unbiased and comprehensive analysis of oncogenic signaling networks to reveal therapeutic targets and personalized(More)
  • 1